During the past decade, SleepMed of South Carolina conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 14 clinical trials were completed, i.e. on average, 82.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 8 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SleepMed of South Carolina" #1 sponsor was "Cephalon" with 7 trials, followed by "Jazz Pharmaceuticals" with 7 trials sponsored, "Vanda Pharmaceuticals" with 3 trials sponsored, "XenoPort, Inc." with 3 trials sponsored and "Fisher and Paykel Healthcare" with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SleepMed of South Carolina" #1 collaborator was "Baker Heart and Diabetes Institute" with 1 trials as a collaborator, "International Diabetes Center at Park Nicollet" with 1 trials as a collaborator, "Mayo Clinic" with 1 trials as a collaborator and "Royal North Shore Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "SleepMed of South Carolina" are "Narcolepsy" (9 trials), "Obstructive Sleep Apnea" (5 trials), "Excessive Daytime Sleepiness" (3 trials), "Excessive Sleepiness" (3 trials) and "Non-24-Hour Sleep-Wake Disorder" (3 trials). Many other conditions were trialed in "SleepMed of South Carolina" in a lesser frequency.

Most popular intervention types in "SleepMed of South Carolina" are "Drug" (27 trials), "Device" (7 trials), "Behavioral" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "JZP-110" (3 trials), "tasimelteon" (3 trials), "ADX-N05" (2 trials) and "Armodafinil" (2 trials). Other intervention names were less common.

The vast majority of trials in "SleepMed of South Carolina" are 36 trials for "All" genders.

Currently, there are NaN active trials in "SleepMed of South Carolina". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in SleepMed of South Carolina, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in SleepMed of South Carolina, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 7 trials that are defined as “Not Applicable".

SleepMed of South Carolina has several departments that took part in Clinical trials: "SleepMed" - 4 trials